Answers are grounded in this paper and cite their sources.
Investigates FR183998 effects on pulmonary ischemia-reperfusion injury, indicating protective benefits.
FR183998 (FR) is a Na+/H+ exchange inhibitor known to protect against cardiac ischemia-reperfusion (I/R) injury. The purpose of this study is to investigate the effects of FR on pulmonary I/R injury.
No takes yet. Share an insight, caveat, or question.
Sunose et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: